Key Takeaway Autoimmune gastric is one of the most overlooked causes of severe B12 deficiency
Beyond appetite regulation: targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss
Comprehensive assessment ensures that semaglutide is deployed effectively to manage weight while addressing broader health concerns
The outcome of such an action is the release of growth hormone (GH), which in turn raises IGF-1
Patients with specific FTO variants, for example, may show stronger appetite suppression with higher-dose semaglutide, while those with certain GIPR polymorphisms might benefit from tirzepatide's dual GLP-1/GIP mechanism
Multiple factors can affect weight-loss results, including medication timing, eating patterns, sleep quality, and stress levels